Without enough protein, its easier to lose muscle along with fat
Global Risk Management Survey Better Decisions Across Interconnected Risk and People Issues
Long-term cardiovascular data from tirzepatide studies continues to emerge, showing sustained benefits through 2+ years of treatment
Clinical trial data shows significant weight regain within 12 months of discontinuation
9 Similarly, in a combined analysis of the PARADIGM-HF (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) and PARAGON-HF (Prospective Comparison of ARNI with ARB Global Outcomes in HF with Preserved Ejection Fraction) trials suggested that patients with HFmrEF would most likely benefit from sacubitril/valsartan compared with renin-angiotensin system inhibitors, which was not the case in those with truly normal LVEF
At The Dietologist, as fertility dietitians, we frequently see clients having difficulty meeting nutrient requirements while taking GLP-1 medications due to appetite suppression